Skip to main content
. 2020 Sep 12;8(1):48–59. doi: 10.1093/nop/npaa057

Table 5.

Scores on Study Variables and Risk Factor Analysis for Caregiver Participants

LSD (n = 20) HSD (n = 24) Univariate
Variable Mean (SD) Mean (SD) OR 95% CI P
HADS Depression 5.00 (3.95) 5.29 (2.85)
HADS Anxiety 5.90 (3.32) 10.46 (4.62) 1.33 (1.10-1.62) 0.004
EQ-5D Mobility 1.15 (0.37) 1.25 (0.61)
EQ-5D Pain 1.45 (0.69) 1.71 (0.55)
EQ-5D Health VAS 82.15 (13.07) 76.25 (15.90)
CQOLC Level of stress 1.85 (1.27) 3.08 (1.01) 2.46 (1.35-4.50) 0.003
CQOLC Outlook on life 2.50 (1.70) 3.17 (1.37)
CQOLC Sadness 1.20 (1.11) 2.42 (1.38) 2.12 (1.23-3.64) 0.007
CQOLC Mental strain 1.75 (1.15) 2.42 (1.21) 2.33 (1.30-4.17) 0.005
CQOLC Frustration 1.70 (1.26) 2.04 (1.16)
CQOLC Social support 1.75 (1.33) 1.79 (1.38)
CQOLC Relationship with patient 2.05 (1.70) 1.38 (1.53)
CQOLC Informed about illness 2.70 (1.38) 2.88 (1.45)
CQOLC total 48.45 (26.93) 63.12 (17.96) 1.03 (1.00-1.06) 0.045
ADL 0.15 (0.37) 1.46 (3.60)
Median (range) Median (range)
Weekly care, h 29 (2-168) 150 (2-168) 1.01 (1.00-1.02) 0.038
N (%) N (%)
Medication use (n = 43) Yes 5 (12) 15 (35) 5.63 (1.49-21.20) 0.011
No 15 (35) 8 (19)
Comorbid illness Yes 5 (11) 17 (39) 7.29 (1.91-27.86) 0.004
No 15 (34) 7 (16)

Abbreviations: ADL, activities of daily living; CQOLC, Caregiver Quality of Life Index–Cancer; EQ-5D, EuroQol Five Dimension Questionnaire; HADS, Hospital Depression and Anxiety Scale; HSD, high sleep disturbance; LSD, low sleep disturbance; OR, odds ratio; VAS, visual analog scale.

Only significant results are presented for univariate analyses. Multivariable analysis was not performed because of small sample size.